BioMarin Pharmaceuticals
BMRN
BMRN
390 hedge funds and large institutions have $13.3B invested in BioMarin Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 161 increasing their positions, 121 reducing their positions, and 53 closing their positions.
Holders
390
Holders Change
+2
Holders Change %
+0.52%
% of All Funds
10.41%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.35%
New
58
Increased
161
Reduced
121
Closed
53
Calls
$119M
Puts
$84.2M
Net Calls
+$34.9M
Net Calls Change
-$14.6M
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$181M |
2 |
2
Jennison Associates
New York
|
$722M |
3 |
O
3
OrbiMed
New York
|
$84.4M |
4 |
FAM
4
Fred Alger Management
New York
|
$102M |
5 |
![]()
5
Adage Capital Partners
Boston,
Massachusetts
|
$86.8M |